-
讲者主持列表
查看日程一览表
打印
-
不限 Conference Hall No.1(第一会议厅—主会场)(2F) Conference Hall No.5-A(第五会议厅A厅—会场一)(1F) Conference Hall No.5-B(第五会议厅B厅—会场二)(1F) Conference Hall No.5-C(第五会议厅C厅—会场三)(1F) Conference Hall No.5-D(第五会议厅D厅—会场四)(1F) Conference Hall No.2-A(第二会议厅-A—会场五)(2F) Conference Hall No.2-B(第二会议厅-B—会场六)(2F) Conference Hall No.2-C(第二会议厅-C—会场七)(2F) Conference Hall No.2-AB(第二会议厅-AB—会场八)(2F) Conference Hall No.3(Vascular care)(第三会议厅—会场九)(护理专场)(1F) Convention Hall No.2(第二会议厅—会场十)(2F) Conference Room 201-A(201-A会议室—会场十一)(2F) Conference Room 201-AB(201-AB会议室—会场十二)(2F) Conference Room 201-ABC(201-ABC会议室—会场十三)(2F) Conference Room 201-BC(201-BC会议室—会场十四)(2F) Conference Room 201-D(201-D会议室—会场十五)(2F) Conference Room 201-CD(201-CD会议室—会场十六)(2F) Coference Room No.307(307会议室—会场十七)(3F) Conference Room No.308(308会议室—会场十八)(3F) Conference Hall No.2-VIP-room-A(第二会议室VIP-A房间)(2F) Electronic Poster Machine:Conference Hall No.4(第四会议厅门口)(1F) Satellite Symposium(卫星会)
15:20-17:50
Peripheral arterial disease Moderators: José Fernandes Portugal , Lefeng Qu China , Thomas Karplus Australia , Xiaoyun Luo China 主持: José Fernandes Portugal 曲乐丰 China Thomas Karplus Australia 罗小云 China |
||||||
---|---|---|---|---|---|---|
NO./编号 | Time/时间 | Type/类型 | Topic/题目 | Speaker/讲者 | ||
1 | 15:20-15:30 |
Symposium 专题发言 |
Statin the known unknown. How we got it wrong, good fat is essential for longevity 已知未知的他汀类药物。 我们怎么弄错了,好脂肪对长寿至关重要 |
Sherif Sultan Sherif Sultan Ireland |
||
2 | 15:30-15:40 |
Symposium 专题发言 |
Endo-vascularization or conservative therapy for intermittent claudication? ----Thomas Karplus 对于下肢跛行患者,腔内治疗还是保守治疗? |
Thomas Karplus Thomas Karplus Australia |
||
3 | 15:40-15:50 |
Symposium 专题发言 |
Medical management of peripheral arterial disease. New Strategies 外周动脉疾病的药物治疗的新策略 |
Pavel Poredos Pavel Poredos Slovenia |
||
4 | 15:50-16:00 |
Symposium 专题发言 |
When to use antiplatelet testing in clinical practic 在临床实践中什么时候使用抗血小板测试 |
Jorge Saucedo Jorge Saucedo United States |
||
5 | 16:00-16:10 |
Symposium 专题发言 |
Current evidence in dual antiplatelet for anticoagulated patients- 抗凝患者双联抗血小板治疗的目前证据 |
Jorge Saucedo Jorge Saucedo United States |
||
6 | 16:10-16:20 |
Symposium 专题发言 |
Vascular protection by the non-vitamin K antagonist oral anticoagulants the novelty from COMPASS 非维生素K拮抗剂口服抗凝剂对血管的保护作用,来自COMPASS 研究 |
Salvatore Novo Salvatore Novo Italy |
||
7 | 16:20-16:30 |
Symposium 专题发言 |
Risk factors for developing peripheral artery disease in low and middle-income countries 中低收入国家外周动脉疾病发生的高危因素 |
Gerry Fowkes Gerry Fowkes United Kingdom |
||
8 | 16:30-16:40 |
Symposium 专题发言 |
Updates for ASO 下肢动脉硬化闭塞症的现状 |
Michael.Sywe-Yung Chin Michael.Sywe-Yung Chin United States |
||
9 | 16:40-16:50 |
Symposium 专题发言 |
Mediterranean diet trial on the prevention of chronic cardiovascular diseases: a pilot study 地中海饮食试验预防慢性心血管疾病:初步研究 |
Nicos Angelides Nicos Angelides Cyprus |
||
10 | 16:50-17:00 |
Symposium 专题发言 |
Establishing a Foot Clinic is the key of success in patients with critical limb ischemia 建立足部诊所是成功治疗重度下肢缺血患者的关键 |
Nicola Troisi Nicola Troisi Italy |
||
11 | 17:00-17:10 |
Symposium 专题发言 |
Current clinical significance of Buerger’s disease in Japan and pathogenic relationship with atherosclerotic lesions 日本Buerger病的当前临床意义和与动脉硬化病变的发病关系 |
Takehisa Iwai Takehisa Iwai Japan |
||
12 | 17:10-17:20 |
Symposium 专题发言 |
Versatility of the cover stent in the treatment of challenging peripheral disease 覆盖支架在治疗具有挑战性的周围血管疾病中的多功能性 |
|
||
13 | 17:20-18:00 |
Discussion 讨论 |